Replies to post #239388 on Biotech Values

[DewDiligence]

RCKT acquires RCOR for $2.34/sh in stock—a 23% premium to yesterday’s close:

https://finance.yahoo.com/news/rocket-pharmaceuticals-acquire-renovacor-extending-100000942.html

The nominal deal value is $53M.

RCOR went public one year ago via a SPAC merger (#msg-165745950). RCKT (the buyer) went public via a reverse-merger in 2017 (#msg-134563146).